Should Living Donors Be Used for Patients with Heptocellular Cancer?

The MacLean Center Seminar Series: Should Living Donors Be Used for Patients with Heptocellular Cancer?

Elizabeth Pomfret, MD, PhD, FACS, Chair of the Department of Transplantation at the Lahey Clinic, debates if living donors should be used for patients with heptocellular cancer (HCC). Organ transplantation raises almost every important medical ethical ...

Summary

Elizabeth Pomfret, MD, PhD, FACS, Chair of the Department of Transplantation at the Lahey Clinic, debates if living donors should be used for patients with heptocellular cancer (HCC).

Organ transplantation raises almost every important medical ethical issue, including: standards for determining death, informed consent, the fair allocation of scarce resources, research on human subjects, global health concerns, and more. The MacLean Center’s Seminar Series has examined Ethical Issues in Organ Transplantation.

This year’s interdisciplinary seminar series was organized by Mark Siegler, MD, Director of the MacLean Center. The seminars are cosponsored by the Transplant Center at the University of Chicago Medicine.

Learn more about the MacLean Center for Clinical Medical Ethics at http://medicine.uchicago.edu/centers/ethics/welcome.html

Details

Duration:
1 hour, 6 minutes, 48 seconds
Recorded:
November 7, 2012
Published: December 21, 2012
Presented by:
Produced by: